Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India · Delayed Price · Currency is INR 1,283.00
+15.50 (1.22%)
Jun 5, 2026, 3:29 PM IST
Dr. Reddy's Laboratories Market Cap
Dr. Reddy's Laboratories has a market cap or net worth of 1.06 trillion as of June 5, 2026. Its market cap has increased by 3.79% in one year.
Market Cap
1.06T
Enterprise Value
1.06T
Revenue
335.93B
Ranking
n/a
PE Ratio
24.83
Stock Price
1,283.00
Market Cap Chart
Since May 31, 1999, Dr. Reddy's Laboratories's market cap has increased from 21.00B to 1.06T, an increase of 4,965.67%. That is a compound annual growth rate of 15.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 1.06T | 0.55% |
| Dec 31, 2025 | 1.06T | -8.50% |
| Dec 31, 2024 | 1.16T | 19.80% |
| Dec 29, 2023 | 965.41B | 37.28% |
| Dec 30, 2022 | 703.23B | -13.66% |
| Dec 31, 2021 | 814.50B | -5.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.75T |
| Cipla | 1.11T |
| Zydus Lifesciences | 1.08T |
| Mankind Pharma | 978.20B |
| Aurobindo Pharma | 830.08B |
| Laurus Labs | 752.72B |
| Alkem Laboratories | 630.59B |
| Glenmark Pharmaceuticals | 613.50B |